Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [


Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 14 10 2020
accepted: 18 01 2021
pubmed: 8 2 2021
medline: 26 10 2021
entrez: 7 2 2021
Statut: ppublish

Résumé

To establish the feasibility of shorter acquisition times (and by analogy, applied activity) on tumour detection and lesion contrast in digital PET/CT. Twenty-one randomly selected patients who underwent oncological [ Overall n = 100 lesions were identified in the 2 min and 1 min/bp acquisitions and n = 98 lesions in the 30 s/bp acquisitions. Agreement between the three acquisitions with respect to lesion number and tumour-to-background ratio showed almost perfect agreement (K's α = 0.999). SUVmax, SUVmean and TBR likewise showed > 98% agreement, with longer acquisitions being associated with slightly higher mean TBR (2 min/bp 7.94 ± 4.41 versus 30 s/bp 7.84 ± 4.22, p < 0.05). Shorter acquisition times have traditionally been associated with reduced lesion detectability or the requirement for larger amounts of radiotracer activity. These data confirm that this is not the case for new-generation digital PET scanners, where the known higher sensitivity results in clinically adequate images for shorter acquisitions. Only a small variation in the semi-quantitative parameters SUVmax, SUVmean and TBR was seen, confirming that either reduction of acquisition time or (by analogy) applied activity can be reduced as much as 75% in digital PET/CT without apparent clinical detriment.

Identifiants

pubmed: 33550515
doi: 10.1007/s12149-021-01588-6
pii: 10.1007/s12149-021-01588-6
pmc: PMC7981298
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-492

Références

J Nucl Med. 2012 Jul;53(7):1041-7
pubmed: 22627001
J Nucl Med. 2015 Sep;56(9):1378-85
pubmed: 26159588
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1745-1750
pubmed: 30617960
J Nucl Med. 2019 Apr;60(4):561-567
pubmed: 30361382
EJNMMI Res. 2019 Dec 10;9(1):106
pubmed: 31823097
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
J Nucl Med. 2020 Nov;61(11):1684-1690
pubmed: 32198313
J Nucl Med. 2020 May;61(5):764-771
pubmed: 31628214
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1222-1225
pubmed: 30859431
J Nucl Med. 2020 Sep;61(9):1406-1410
pubmed: 32245895
PLoS One. 2020 Mar 16;15(3):e0229560
pubmed: 32176698
J Nucl Med. 2020 Sep;61(9):1376-1380
pubmed: 32005768
J Nucl Med. 2019 Jul;60(7):1031-1036
pubmed: 30630944
J Nucl Med. 2019 Aug;60(8):1059-1065
pubmed: 30683762
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
EJNMMI Phys. 2018 Apr 18;5(1):9
pubmed: 29666972
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1383-1390
pubmed: 30631910
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):614-623
pubmed: 31792572
J Nucl Med. 2014 Sep;55(9):1411-6
pubmed: 24947059
Nucl Med Commun. 2016 Oct;37(10):1088-94
pubmed: 27281357
J Nucl Med. 2018 Dec;59(12):1817-1822
pubmed: 29880506
J Nucl Med. 2020 Oct;61(10):1448-1454
pubmed: 32060217
Sci Rep. 2020 Jan 15;10(1):368
pubmed: 31942032
J Nucl Med. 2020 Feb;61(2):189-193
pubmed: 31324710
Radiology. 2018 Jan;286(1):249-259
pubmed: 28914600
J Nucl Med. 2011 Feb;52(2):303-10
pubmed: 21233186

Auteurs

Ian Alberts (I)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland. ian.alberts@insel.ch.

Christos Sachpekidis (C)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

George Prenosil (G)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Marco Viscione (M)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Karl Peter Bohn (KP)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Clemens Mingels (C)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Kuangyu Shi (K)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Ali Ashar-Oromieh (A)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Axel Rominger (A)

Department of Nuclear Medicine. Inselspital, Bern University Hospital, University of Bern, Freiburgstr. 18, 3010, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH